(Oct 24): Malaysia’s Budget 2026 and the 13th Malaysia Plan mark a pivotal shift: the country is moving from managing subsidies to building high-value, technology-driven sectors.
The budget declared a food-security tax incentive for domestic sales and a RM10 million agri-technology fund. This is where the promise of modern biotechnology — in particular gene editing for crops — becomes not simply a scientific luxury but an economic imperative.
Globally, the food system must increase production by 70% by 2050 to feed a projected 10 billion people. At the same time, climate change and disrupted supply chains pressurise import-dependent nations like ours. Precision breeding through gene editing can deliver drought-resistant rice, disease-tolerant oil palm, and nutrient-enhanced vegetables far faster than conventional methods. These applications translate into tangible economic value: higher yields, lower input costs and earlier market entry.
Take, for example, a small deletion (SDN-1) in a gene that governs heat tolerance in rice. It mimics a naturally occurring variant yet replicates in one crop cycle what might have taken a decade otherwise. Or consider a banana edit that silences a viral susceptibility gene, enabling yield scales up without chemical sprays. These are not distant blue-sky ideas but active research pathways. They promise both agricultural resilience and commercial opportunity.
Yet innovation must be matched by governance. Under our current regulatory framework, the Biosafety Act 2007 was designed when transgenic GMOs were the new frontier; it focuses on how a modification was made rather than what the final crop actually does. This throws gene-edited crops — especially those without foreign DNA — into regulatory ambiguity. For business, this translates into project delays, uncertain compliance costs, and investment risk. For public-sector research, it means slower translation of discoveries into field-ready products.
What Malaysia needs is a principle-based, product-focused regulatory system where risk assessment depends on the trait produced, not the tool used. Low-risk edits akin to natural mutations can follow a streamlined pathway. More complex edits — ones that introduce novel proteins or pathways — undergo full evaluation. This approach delivers regulatory efficiency, investment clarity, and encourages innovation while maintaining safety and public trust.
Policymakers should seize this moment. The economy is projected to grow 4%-4.5% in 2026. If Malaysia channels a fraction of the RM419 billion development outlay into agribiotech — say one percent — the gains in productivity and export potential could dramatically exceed the initial cost.
The only limiting factor is governance inertia. Revising legislation to codify product-based mandates, establishing tiered assessment pathways, and building transparent monitoring systems will signal to investors that Malaysia is open for high-tech agri-investment.
Business stakeholders should also pay attention. The budget’s food-security incentive rewards domestic sales of new agricultural projects. Biotechnology firms, agritech startups, and even commodity producers have an opening to move from commodity dependence into value-adding innovation.
Pairing gene-edited crops with digital agriculture, carbon-sequestration strategies, and ESG reporting opens wider value chains — domestic and Asean-wide. As Asean sets its 2045 goal for a resilient and innovative community, Malaysia must claim a leadership role in biotechnology, as well as digital.
Consumers and communities matter too. Technology that increases yield and resilience in small-holder contexts means better incomes, lower food prices and stronger supply chains.
Yet, public trust must be earned. Transparent reporting, public-good research, and clear benefit-sharing arrangements are essential. The narrative must shift: gene editing not as an exotic intervention, but as a smart, science-based upgrade of our food system.
We must also address the “innovation gap”. Malaysia ranked 33rd in the Global Innovation Index in 2024. Biotechnology offers a means to close that gap. But it demands regulatory clarity, pro-investment policy, and public-sector leadership. Without that, other Asean neighbours will capture the value chain while we remain commodity exporters.
The bottom line: gene editing is more than a research theme. It is a strategic economic lever. It dovetails with Budget 2026’s technology-and-food-security agenda and Asean’s vision for 2045.
If the policy-makers adjust the rules, if industry steps up, if society accepts the pathway, Malaysia could leapfrog into a leadership position in agricultural biotechnology — serving our own food security, creating export income and positioning the nation for a future where agribiotechnology, not just bits and machinery, drives growth.
Dr Hoe-Han Goh is an Associate Professor at Universiti Kebangsaan Malaysia, leading the Plant Functional Genomics Research Group at the Institute of Systems Biology.